A radiometric method to determine the MIC of ansamycin (LM427) for Mycobacterium avium complex clinical isolates has been developed. It is based on a comparison of the conventional growth curve determination and the radiometric detection of growth (growth index) in the same liquid medium (7H12 broth). This new method requires less time and labor than does a conventional determination of MIC in liquid medium (CFU). Other advantages of this method include relatively short periods of exposure of the drug to 3TC and the composition of 7H12 broth, which has practically no substrates which could absorb or bind the drug. Thus, a more accurate estimation of the MIC in this medium can be expected than by the conventional agar dilution (proportion) method. The MICs of ansamycin appeared to be higher in agar plates than in 7H12 broth. More than 70% of the isolates had a broth-determined MIC one to three times lower than the average peak concentration of ansamycin achieved in sera of patients. The wide range of MICs suggests the importance of testing susceptibility in broth with many concentrations in addition to, or rather than in, agar plates with concentrations of 2.0 or 1.0 ,ug/ml only. Taking into account relatively low levels of ansamycin in sera of patients, it would be appropriate to compare the MICs with the levels in serum to make the outcome of chemotherapy more predictable.
Ansamycin (LM427; spiropiperidyl rifamycin) has been reported as having substantial in vitro activity against mycobacteria, especially against Mycobacterium avium complex (12, 17) . This antimycobacterial agent is widely used in the United States as an experimental drug, primarily for the treatment of disseminated M. avium infection in acquired immune deficiency syndrome patients. However, the clinical effect of this treatment is so far unknown. This use of ansamycin is based on in vitro studies which indicated that a high percentage of M. avium complex strains were inhibited by 1.0 and 2.0 pug of ansamycin per ml incorporated into 7H10 or 7H11 agar medium. However, several major questions remain to be answered about the utility of this compound in such infections. It is not known whether there is any correlation between the MIC of this drug for the infecting organism in vitro and the clinical (in vivo) response. It is not known whether the concentrations of ansamycin achieved in blood and tissues of patients is sufficient to pLg/ml) were used for primary titrations, followed by another experiment with an additional set of concentrations if the results in the first experiment were "out of scale." The lowest concentration of ansamycin that inhibited the increase in GI for at least 4 to 5 days while a daily increase in GI occurred in the 1:100 control or which produced a daily GI increase no greater than that in the 1:100 control was considered the radiometric MIC. MIC determinations in 7H12 broth by plating. The experiments for MIC determination in 7H12 broth by plating were conducted as described above for radiometric MIC determinations, but duplicates and triplicates were used for each concentration, as well as for both controls. Samples from alternate vials were removed for daily plating. Two or three 10-fold dilutions of each sample were used for plating (in agreement with preliminary studies) so as to have a range of 50 to 500 CFU per plate. Four to six 7H11 agar plates were used for each sample; each dilution was inoculated at a volume of 0.5 ml, which was distributed by tilting the plate (not by use of a spreader). Incubation at 37°C was carried out for 12 to 14 days, and the colonies were then counted. The MIC was the lowest concentration that inhibited more than 99% of the bacterial population.
Determinations of the concentrations of ansamycin in broth cultures and sera of patients. To estimate the concentrations of ansamycin in broth cultures, 42 vials of 7H12 broth in each experiment were supplemented with the same concentration of the drug, and half of these vials were inoculated with a strain of M. avium resistant to the given concentration. The vials were incubated at 37°C, and duplicate vials both with and without the organisms were removed from the incubator every day during a period of 10 to 12 days. The contents of both vials were filtered through membrane filters (0.22-,um pore size; Millipore Corp., Bedford, Mass.). These samples were stored at -70°C until days 10 to 12, when all were tested for ansamycin concentration. Levels in serum were determined in patients considered for treatment with ansamycin. Informed consent was obtained from all patients. Antimicrobial agents were withheld for 24 h, and 1 dose of ansamycin (300 mg) was given orally. Blood was collected before the drug was given and then at 2, 4, 6, 12, and 24 h after the loading dose. Each serum specimen was tested twice.
The concentrations of ansamycin in broth cultures and sera were determined by conventional agar plate diffusion bioassay (5, 8) with Micrococcus luteus ATCC 9341 as the target organism (8) . The standards for experiments with broth cultures were prepared in diluting fluid (see above); for experiments with sera of patients, the standards were prepared in pooled human sera. Results were determined by regression analysis.
Agar dilution method. The study of susceptibility to ansamycin by the agar dilution method was a part of the indirect drug susceptibility test, performed routinely by the proportion method (2, 16) with 12 antituberculosis drugs. Different concentrations of ansamycin (2.0 to 0.015 ,ug/ml), as well as different concentrations of other drugs, were incorporated into 7H11 agar. Two sets of quadrant petri dishes (one quadrant in each plate contained drug-free medium, and three other quadrants contained the same medium with different drug concentrations) were inoculated with each culture, one with the dilution of 10-3 and the other with the dilution of i0-5, made from a broth culture adjusted to the optical density of McFarland standard no. 1. The higher inoculum consisted of 1 x 104 to 3 x 104 CFU; the lower inoculum contained 100 to 300 CFU. Each quadrant was inoculated with 0.1 ml of the bacterial suspension with a repetitive microliter pipette (Eppendorf Repeater 4780; Brinkmann Instruments, Inc., Westburg, N.Y.), and the inoculum was distributed by tilting the plate. Incubation at 37°C in the presence of 5% CO2 was carried out for 12 days. For most of the isolates, the number of colonies in the controls was in the range of 100 to 300 when the suspension diluted to 10-was the inoculum. In accordance with the principles of the proportion method (2, 16), the organisms were considered "susceptible" to certain concentrations if the number of colonies in the drug-containing quadrant was less than 1% of the number of colonies in the drug-free quadrant. The lowest concentration that inhibited more than 99% of the bacterial population was considered the MIC determined by this method. The term "susceptibility" is used here to describe only the effects of certain concentrations of the drug on the bacterial population because of paucity of any information about the clinical effect of ansamycin. RESULTS MIC determinations in 71112 broth by radiometric and conventional methods. The initial concentration of bacteria in 7H12 broth (see Materials and Methods) was between 104 and 105 CFU/ml. Within 4 to 8 days, the number of CFU per milliliter in drug-free medium (undiluted control) reached the maximum of about 108 CFU/ml. After a period of stabilization (2 to 4 days), the number of CFU per milliliter began to decline. The maximum CFU of M. avium complex strains found per milliliter in 7H12 broth was about 100 times higher than that found with M. tuberculosis cultures under the same conditions (9) . The increase in daily GI readings correlated well with the growth curve during the period of active growth (Fig. 1A) . The subsequent decline in daily GI readings was much sharper and was observed before a reduction in the number of CFU per milliliter was seen. This course of events had been observed previously for M. tuberculosis cultures (9) , and it was suggested that the limit of growth in 7H12 broth probably was due to the limited amount of nutrient substances in this medium, consumption of which affects the tnetabolism of bacteria and the release of "4CO2 (GI readings) before the decline in the number of viable organistns can be detected. The growth curves and daily GI reading curves also correlated well in the presence of ansamycin. The subinhibitory concentrations (as in Fig. 1B) delayed the beginning and lowered the intensity of growth detected by both CFU determinations and GI readings. If the lowest concentration considered the MIC inhibited the growth for at least 4 to 5 days, this inhibition was detected by both methods (counting of CFU and GI) and showed good correlation of the curves (Fig. 1C) . Very often, such a concentration provided complete inhibition for the first 4 to 5 days only, after which growth was detected by both CFU determinations and GI readings. This phenomenon took place in experiments in which the drug was added either at the beginning or after a few days of cultivation. These results correspond with the data on deterioration of ansamycin in the medium (see below). The correlation between curves of growth and GI readings in drug-free and drug-containing 7H12 broth was studied with four strains of M. avium complex that were inhibited by different MICs of ansamycin. All the experiments confirmed that the daily GI readings truly reflect the multiplication of M. avium complex strains in drug-free 7H12 broth during the period of active growth only. The inhibition of daily GI increase in drug-containing vials reflects the true inhibition of growth. These data correspond with our previous finding in regard to the use of a GI criterion for M. tuberculosis as well (9) . It is essential in radiometric MIC titration to compare the curve of GI daily readings in drug-containing vials with that of the 1:100 control, as defined above. The daily GI increase in the vial with the concentration considered the MIC was less than that in the 1:100 control, which is an indication that less than Despite the different levels of susceptibility found by the agar and broth methods, the majority of strains considered among the most susceptible by the agar method were found to be the most susceptible by the broth method, and the most resistant strains by the agar method were also the most resistant strains by the broth method (Fig. 2) . Among 58 strains with MICs of 0.25 ,ug/ml or less determined in agar, 82.8% had broth-determined MICs of 0.125 ,ug/ml or less. Among 38 strains with MICs of 2.0 p.g/ml or more by the agar method, 85.5% had broth-determined MICs of 0.25 ,ug/ml or more.
Ansamycin degradation in 7H12 broth cultures. The halflife of ansamycin in bacteria-free 7H12 broth at 37°C in the presence of 7% CO2 in the air above the medium was 157 to 197 h ( Table 2 strains completely or partially resistant to the tion inhibiting growth of more than 99% of the bacterial tions of the drug chosen for this study.
population (11, (13) (14) (15) . if ansamycin in sera of patients. Peak levels of drug
The comparison of the MICs detected in 7H12 broth and were achieved 4 h after the administration of 300 by the agar plate method has demonstrated that most of the ;amycin (Fig. 3) . The average peak level was 0.38 strains were much more susceptible when the test was done 25 0.58), which approximates information pre-in liquid medium. One of the possible explanations for this the manufacturer of the drug (0.49 ,ug/ml).
phenomenon is the differences in experimental conditions in agar and broth. Difference in the inoculum size, known to be a'cause of different results of susceptibility in agar and broth DISCUSSION media, was not likely the case in this study. For the agar plate method, two inocula were used to determine if a strain ,ment of 7H12 bro,th offers an opportunity to com-contained 1% drug-resistant mutants; the higher inoculum results of MICs determined by conventional sam-consisted of 1 x 104 to 3 x 104 cells (CFU), and the lower plating (CFUJ) with results of daily radiometric inoculum contained 100 to 300 CFU per drug-free or drugof growth (GI). Pre,viously (9) , such comparisons containing plate quadrant. For the broth method also, two ,ood agreement when the MICs of cephalosporins inocula were used for the drug-free media (two controls); the r. tuberculosis were determined. In the present higher inoculum produced an initial concentration of 104 to od correlation between the growth, curve and 0I 105 CFU/ml, and the lower inoculum (1:100 control) proling curve was found in the determination of duced a concentration of 100 to 1,000 CFU/ml. The drugn MICs for M. avium complex strains. These containing vials were inoculated with the higher inoculum I to the establishment of a radiometric determina-only. So the lower MICs in broth were obtained despite the Le MIC, which iS a fast, convenient, and reliable fact that the inoculum in broth was not lower than with agar equiring much less time and labor than does a plates. The more likely explanation for the differences in nal determination in liquid medium. This approach MICs between agar and broth methods is the instability of tial in this study, which was to determine the range the drug during the incubation at 37°C. In our previous f ansamycin by testing a substantial number of M. studies with more stable drugs (9) , no significant differences mplex st,rains. MIC deter;mination by the radio-in MICs were found between the agar and broth methods. ethod presents certain limitations respecting the The results were different in this study with ansamycin. The size, which must provide an initial concentration agar plate method requires at least 12 days of incubation to im organisms in range of i0 to 105 CFU/ml. Uinder obtain visible growth in controls and to detect the effect of dlitions, the growth in drug-free medium (undiluted inhibition, whereas the effect in 7H12 broth can be detected chieves its maximoum GI within no less than 4 days by radiometric readings within a few days of the addition of no more than, 8 days, the optimum time span for the drug. The actual active concentrations in the agar of ansamycin activity. Another requirement is that medium are probably much lower than those originally )nal control with a 1:10.0 inoculum (102 to 103 incorporated into the agar, due to the deterioration during a be used. The lowest concentration which produces longer period of incubation. This assumption is in concor-I increase no greater than that in the 1:100 control dance with the observed results of degradation of ansamycin C, which, in other words, is the lowest concentra-at 37°C even in liquid medium. Therefore, (6) . Obviously, since this methodology is new, its utility must be tested in a clinical study.
